{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:42:09Z","timestamp":1774316529289,"version":"3.50.1"},"reference-count":25,"publisher":"Japanese Circulation Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2020,3,25]]},"DOI":"10.1253\/circj.cj-19-1041","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T22:03:47Z","timestamp":1583186627000},"page":"650-655","source":"Crossref","is-referenced-by-count":8,"title":["Long-Term Clinical Outcomes of Autologous Bone Marrow Mononuclear Cell Implantation in Patients With Severe Thromboangiitis Obliterans"],"prefix":"10.1253","volume":"84","author":[{"given":"Farina","family":"Mohamad Yusoff","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kajikawa","sequence":"additional","affiliation":[{"name":"Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Takaeko","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Maruhashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuki","family":"Kihara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumu","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Biology and Medicine, Hiroshima University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihito","family":"Higashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University"},{"name":"Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hida N, Ohta T. Current status of patients with Buerger disease in Japan. <i>Ann Vasc Dis<\/i> 2013; 3: 617\u2013623.","DOI":"10.3400\/avd.oa.13-00012"},{"key":"2","unstructured":"2. Roncon de Albuquerque R, Delgado L, Correia P, Torrinha JF, Serr\u00e3o D, Braga A. Circulating immune complexes in Buerger\u2019s disease: Endarteritis obliterans in young men. <i>J Cardivasc Surg<\/i> 1989; 30: 821\u2013825."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Iwai T, Inoue Y, Umeda M, Huang Y, Kurihara N, Koike M, et al. Oral bacteria in the occluded arteries of patients with Buerger disease. <i>J Vasc Surg<\/i> 2005; 42: 107\u2013115.","DOI":"10.1016\/j.jvs.2005.03.016"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Iwai T, Inoue Y, Umeda M. Buerger disease, smoking, and periodontitis. <i>Ann Vasc Dis<\/i> 2008; 1: 80\u201384.","DOI":"10.3400\/avd.AVDct00108"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Papa MZ, Adar R. A critical look at thromboangiitis obliterans (Buerger\u2019s disease). <i>Perspect Vasc Surg Endovasc Ther<\/i> 1992; 5: 1\u201318.","DOI":"10.1177\/153100359200500102"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Adar R, Papa MZ, Halpern Z, Mozes M, Shoshan S, Sofer B, et al. Cellular sensitivity to collagen in thromboangiitis obliterans. <i>N Engl J Med<\/i> 1983; 308: 1113\u20131116.","DOI":"10.1056\/NEJM198305123081901"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kinlay S. Management of critical limb ischemia. <i>Circ Cardiovasc Interv<\/i> 2016; 9: e001946.","DOI":"10.1161\/CIRCINTERVENTIONS.115.001946"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Higashi Y, Miyata T, Shigematsu H, Origasa H, Fujita M, Matsuo H, et al. Two-year follow-up of vascular events in peripheral arterial disease treated with antiplatelet agents: A prospective observational multicenter cohort study (SEASON). <i>Sci Rep<\/i> 2016; 7: 6095.","DOI":"10.1038\/s41598-017-06597-y"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). <i>Eur J Vasc Endovasc Surg<\/i> 2007; 33(Suppl 1): 1\u201375.","DOI":"10.1016\/j.ejvs.2006.09.024"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. 2011 Writing Group Members; 2005 Writing Committee Members; ACCF\/AHA Task Force Members. 2011 ACCF\/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): A report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. <i>Circulation<\/i> 2011; 124: 2020\u20132045.","DOI":"10.1161\/CIR.0b013e31822e80c3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. JCS Joint Working Group. Guideline for management of vasculitis syndrome (JCS 2008): Digest version. <i>Circ J<\/i> 2011; 75: 474\u2013503.","DOI":"10.1253\/circj.CJ-88-0007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Idei N, Soga J, Hata T, Fujii Y, Fujimura N, Mikami S, et al. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: A comparison of atherosclerotic peripheral arterial disease and Buerger disease. <i>Circ Cardiovasc Interv<\/i> 2011; 4: 15\u201325.","DOI":"10.1161\/CIRCINTERVENTIONS.110.955724"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. <i>Am Heart J<\/i> 2008; 156: 1010\u20131018.","DOI":"10.1016\/j.ahj.2008.06.025"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomized controlled trial. <i>Lancet<\/i> 2002; 360: 427\u2013435.","DOI":"10.1016\/S0140-6736(02)09670-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yusoff FM, Kajikawa M, Matsui S, Hashimoto H, Kishimoto S, Maruhashi T, et al. Review of the long-term effects of autologous bone-marrow mononuclear cell implantation on clinical outcomes in patients with critical limb ischemia. <i>Sci Rep<\/i> 2019; 9: 7711.","DOI":"10.1038\/s41598-019-44176-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kondo K, Yanishi K, Hayashida R, Shintani S, Shibata R, Murotani K, et al. Long-term clinical outcomes survey of bone marrow-derived cell therapy in critical limb ischemia in Japan. <i>Circ J<\/i> 2018; 82: 1168\u20131178.","DOI":"10.1253\/circj.CJ-17-0510"},{"key":"17","unstructured":"17. Buerger L. The circulatory disturbances of the extremities, including gangrene, vasomotor and trophic disorders. Philadelphia: W.B. Saunders Company, 1924."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Le Joncour A, Soudet S, Dupont A, Espitia O, Koskas F, Cluzel P, et al. Long-term outcome and prognostic factors of complications in thromboangiitis obliterans (Buerger\u2019s disease): A multicenter study of 224 patients. <i>J Am Heart Assoc<\/i> 2018; 7: e010677.","DOI":"10.1161\/JAHA.118.010677"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. The Japanese Society for Vascular Surgery JCLIMB Committee; NCD JCLIMB Analytical Team. 2016 JAPAN Critical Limb Ischemia Database (JCLIMB) annual report. <i>Ann Vasc Dis<\/i> 2019; 12: 109\u2013135.","DOI":"10.3400\/avd.ar.19-00012"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rivera-Chavarr\u00eda IR, Brenes-Gutierrez JD. Thromboangiitis obliterans (Buerger\u2019s disease). <i>Ann Med Surg (Lond)<\/i> 2016; 7: 79\u201382.","DOI":"10.1016\/j.amsu.2016.03.028"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Cooper L, Tse T, Mikhail M, McBane R, Stanson A, Ballman K. Long-term survival and amputation risk in thromboangiitis obliterans (Buerger\u2019s disease). <i>J Am Coll Cardiol<\/i> 2004; 44: 2410\u20132411.","DOI":"10.1016\/j.jacc.2004.09.029"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Vijayakumar A, Tiwari R, Kumar Prabhuswamy V. Thromboangiitis Obliterans (Buerger\u2019s disease): Current practices. <i>Int J Inflam<\/i> 2013; 2013: 156905.","DOI":"10.1155\/2013\/156905"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, Duan J, et al. Augmentation of postnatal neovascularization with autologous bone marrow implantation. <i>Circulation<\/i> 2001; 103: 897\u2013903.","DOI":"10.1161\/01.CIR.103.6.897"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Aulivola B, Hile CN, Hamdan AD, Sheahan MG, Veraldi JR, Skillman JJ, et al. Major lower extremity amputation: Outcome of a modern series. <i>Arch Surg<\/i> 2004; 139: 395\u2013399.","DOI":"10.1001\/archsurg.139.4.395"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Guo J, Guo L, Cui S, Tong Z, Dardik A, Gu Y. Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results. <i>Stem Cell Res Ther<\/i> 2018; 9: 43.","DOI":"10.1186\/s13287-018-0784-6"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/4\/84_CJ-19-1041\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T03:20:02Z","timestamp":1585365602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/4\/84_CJ-19-1041\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,25]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-1041","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,25]]}}}